Vinva Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$255K Buy
+1,360
New +$251K ﹤0.01% 424
2025
Q4
Sell
-38,704
Closed -$5.36M 406
2025
Q3
$5.36M Sell
38,704
-20,158
-34% -$2.72M 0.1% 177
2025
Q2
$7.42M Buy
+58,862
New +$7.33M 0.19% 132
2025
Q1
Sell
-1,874
Closed -$281K 386
2024
Q4
$281K Buy
+1,874
New +$316K 0.01% 386
2023
Q4
Sell
-1,997
Closed -$515K 394
2023
Q3
$515K Sell
1,997
-2,817
-59% -$753K 0.05% 294
2023
Q2
$1.36M Sell
4,814
-56
-1% -$16.7K 0.12% 192
2023
Q1
$1.34M Buy
+4,870
New +$1.35M 0.11% 208

Other funds holding BIIB

Vinva Investment Management's BIIB Position: Q1 2026 in Review

Vinva Investment Management opened a new position in Biogen (BIIB) in Q1 2026: 1,360 shares worth $255K. The stake represents ﹤0.01% of the portfolio and ranks #424 among its holdings. This is a return to the name: Vinva Investment Management previously reported a position in BIIB as recently as Q3 2025.

Vinva Investment Management first reported a position in BIIB in Q1 2023 and has held it in 7 quarters since. The position peaked at $7.42M in Q2 2025. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Vinva Investment Management held 1,360 shares of Biogen worth $255K as of Q1 2026.
  • Biogen was a new Vinva Investment Management position in Q1 2026.
  • Biogen made up ﹤0.01% of Vinva Investment Management's portfolio in Q1 2026, its #424 holding.
  • Vinva Investment Management first reported a position in Biogen in Q1 2023 and has held it in 7 quarters since.
  • Vinva Investment Management's Biogen position peaked at $7.42M in Q2 2025.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Vinva Investment Management's 13F filing for Q1 2026, filed 14 May 2026.